Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289444
Max Phase: Preclinical
Molecular Formula: C23H18N6O2S
Molecular Weight: 442.50
Associated Items:
ID: ALA5289444
Max Phase: Preclinical
Molecular Formula: C23H18N6O2S
Molecular Weight: 442.50
Associated Items:
Canonical SMILES: O=[N+]([O-])c1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1
Standard InChI: InChI=1S/C23H18N6O2S/c30-29(31)19-7-5-18(6-8-19)28-22(16-9-12-24-13-10-16)26-27-23(28)32-14-11-17-15-25-21-4-2-1-3-20(17)21/h1-10,12-13,15,25H,11,14H2
Standard InChI Key: JJNCKTDZBWDREE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 442.50 | Molecular Weight (Monoisotopic): 442.1212 | AlogP: 5.05 | #Rotatable Bonds: 7 |
Polar Surface Area: 102.53 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 3.71 | CX LogP: 4.84 | CX LogD: 4.84 |
Aromatic Rings: 5 | Heavy Atoms: 32 | QED Weighted: 0.21 | Np Likeness Score: -1.84 |
1. Yakkala PA, Panda SR, Naidu VGM, Shafi S, Kamal A.. (2023) Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer., 14 (3): [PMID:36923920] [10.1021/acsmedchemlett.2c00475] |
Source(1):